Which of the following antihypertensive agents in most likely to cause an exaggerated response to an injected catecholamine?
## **Core Concept**
The question tests the understanding of how different antihypertensive agents interact with the sympathetic nervous system, particularly in the context of catecholamine response. Catecholamines, such as adrenaline (epinephrine) and noradrenaline (norepinephrine), act on adrenergic receptors to increase heart rate, blood pressure, and cardiac output. Antihypertensive agents can modify the response to catecholamines through various mechanisms.
## **Why the Correct Answer is Right**
The correct answer, , is likely referring to a class of antihypertensive drugs known as monoamine oxidase inhibitors (MAOIs) or more probably, an agent that leads to an upregulation of adrenergic receptors or interferes with catecholamine degradation or action in a way that an injected catecholamine could cause an exaggerated response. However, the most straightforward explanation relates to the use of **non-selective beta-blockers** or more accurately, **reserpine** and **guanethidine**, but given typical options, it points towards **guanethidine**. Guanethidine works by depleting catecholamines from nerve endings and preventing their release. As a result, there is a compensatory increase in the number of adrenergic receptors. When a catecholamine is administered, the increased receptor sensitivity leads to an exaggerated response.
## **Why Each Wrong Option is Incorrect**
- **Option A:** If referring to a typical diuretic, these generally do not cause an exaggerated response to catecholamines; they work by reducing blood volume and have a mild effect on vascular smooth muscle.
- **Option B:** If this refers to a standard ACE inhibitor or angiotensin receptor blocker (ARB), these decrease blood pressure by inhibiting the renin-angiotensin-aldosterone system (RAAS) and do not directly affect catecholamine response.
- **Option C:** If referring to a calcium channel blocker, these decrease blood pressure by inhibiting calcium entry into vascular smooth muscle and cardiac muscle, not directly influencing catecholamine receptor sensitivity.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **guanethidine** can cause a severe hypertensive response to **catecholamines** due to **receptor hypersensitivity**. This is a critical interaction to recall for exams and clinical practice, especially when managing patients with hypertension on multiple medications.
## **Correct Answer:** .